injection vs oral semaglutide Injectable for Weight Loss Now that oral semaglutide (#wegovy)

System-wide signaling relevance Studied across musculoskeletal, vascular, and gastrointestinal research models

You should not take retatrutide if you have: A personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 A history of pancreatitis Severe gastrointestinal disease, including gastroparesis Known hypersensitivity to any component of the drug You should use extreme caution and only proceed under close medical supervision if you have: Gallbladder disease or a history of gallstones Kidney disease, since dehydration from GI side effects can accelerate kidney damage Diabetic retinopathy, as rapid glucose changes can worsen it A history of eating disorders, since appetite suppression this powerful can interact badly with disordered eating patterns Retatrutide is also not approved for use in pregnancy

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)

Consistency and patience are your best friends on this journey